Phase II study of intravenous and intraperitoneal paclitaxel combined with S-1 for gastric cancer with peritoneal metastasis
Phase 2
- Conditions
- gastric cancer with peritoneal metastasis
- Registration Number
- JPRN-UMIN000002850
- Lead Sponsor
- Department of Surgical Oncology, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
Metastasis to distant organ sites (such as the liver, lungs or bone), other active concomitant malignancies, or other severe medical conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the 1-year overall survival rate
- Secondary Outcome Measures
Name Time Method the overall response rate, efficacy against peritoneal metastasis and safety